SEC Form 4 · accession 0001437749-17-010475
Imunon, Inc. · IMNN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey Wayne Church
Officer — CFO
Period of report
May 30, 2017
Accepted (ET)
Jun 1, 2017 · 4:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000749647
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Celsion Corporation Common StockF1,F2 | $2.69 | May 30, 2017 | A | 48,571 | A | — | May 30, 2027 | Celsion Corporation Common Stock | 48,571 | 48,571 | D |
Explanation of responses
- F1Represents the closing price of Celsion Corporation Common Stock on the date of grant.
- F2The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.